Recruitment and randomization
hematologic malignancy
HEMATOLOGIC MALIGNANCY, RECRUITMENT, SOLID TUMOR
Potentially eligible patients with a diagnosis of active solid tumor or hematologic malignancy were identified for recruitment by a research staff member using the WCCRI's electronic health record system. After confirming eligibility and completing informed consent, participants completed the enrollment survey and were randomly assigned in a 1:1 ratio to one of the two study groups: intervention and control.